I now have comprehensive content. Let me also quickly read the pacemaker-associated tachycardia/malfunction section from Tintinalli/Rosen and Braunwald's complications section.I have extensive material from Braunwald's Heart Disease and Fuster/Hurst's The Heart. Now let me synthesize a comprehensive, detailed answer.
Pacemakers and Cardiac Pacing: A Comprehensive Reference
Sources: Braunwald's Heart Disease (11th Ed), Fuster and Hurst's The Heart (15th Ed), AHA/ACC Guidelines
1. Basic Principles of Cardiac Pacing
A permanent pacemaker system consists of two components:
- Pulse generator - contains the battery, sensing amplifiers, and output circuits
- Leads - deliver the electrical impulse to the myocardium and transmit sensed signals back
Lead Design (Braunwald, Ch. 69)
Fixation types:
- Passive fixation - tined leads that lodge in trabecular myocardium (most common for RV)
- Active fixation - retractable/extendable helical screw, allows placement at any site; tip electrode covered with mannitol that dissolves in bloodstream
Electrode configuration:
- Bipolar leads - both electrodes on the lead (tip cathode, ring anode ~1-2 cm proximal); less susceptible to oversensing from myopotentials or EMI
- Unipolar leads - only distal electrode on lead; pulse generator housing serves as anode; larger "antenna" makes them more susceptible to interference; larger pacing spike on ECG
Lead insulation: Polyurethane or silicone; coaxial design (inner and outer coil) or coradial design (coils individually insulated side by side)
2. The NASPE/BPEG Generic (NBG) Pacemaker Code
The current naming convention for pacemaker modes was established by the 2001 NASPE/BPEG consensus:
| Position | I | II | III | IV | V |
|---|
| Parameter | Chamber(s) Paced | Chamber(s) Sensed | Response to Sensing | Rate Modulation | Multisite Pacing |
| Codes | O, A, V, D | O, A, V, D | O, T, I, D | O, R | O, A, V, D |
- O = None; A = Atrium; V = Ventricle; D = Dual (both)
- Response: T = Triggered; I = Inhibited; D = Dual (triggered + inhibited)
- R (Position IV) = Rate modulation present
3. Common Pacing Modes (Braunwald, Ch. 69)
Single-Chamber Modes
VOO (Fixed-Rate Ventricular Asynchronous)
- Paces only the ventricle, senses nothing, fires asynchronously
- One timing clock: the ventricular escape interval (e.g., 1000 ms = 60 bpm)
- Delivers a pacing pulse regardless of intrinsic rhythm - can cause R-on-T and VF
- Clinical use: Applying a magnet over most pacemakers converts VVI → VOO, useful in the OR to prevent inappropriate inhibition from EMI
VVI (Ventricular Demand/Inhibited)
- Paces V, senses V, inhibited by sensed events
- The sensed ventricular event resets the escape interval
- Adds a ventricular refractory period (VRP) - sensed events during this are ignored (prevents T-wave oversensing, double-counting)
- Main drawback: No AV synchrony - predisposes to pacemaker syndrome
AAI (Atrial Inhibited)
- Paces A, senses A, inhibited by sensed events
- Maintains AV synchrony via native conduction
- Use: Sick sinus syndrome with intact AV conduction (AAIR is the rate-responsive form)
- Cannot be used if significant AV conduction disease is present
AOO / VOO - Asynchronous modes (no sensing); primarily triggered by magnet placement
Dual-Chamber Modes
DDD (Dual Sensing/Pacing/Inhibited+Triggered)
The most physiologic and commonly used mode. Key timing cycles:
- Lower Rate Limit (LRL) - minimum pacing rate
- Upper Rate Limit (URL) - maximum tracking rate in DDD
- AV interval - analogous to PR interval; typically programmed ~150-180 ms at rest (hemodynamically optimal ~150 ms)
- Post-Ventricular Atrial Refractory Period (PVARP) - after each V event, atrial channel is refractory to prevent sensing retrograde P-waves
- Total Atrial Refractory Period (TARP) = AV interval + PVARP
Four possible states in DDD:
- P-sensed, V-paced (AS-VP): Sensed native P wave triggers AV interval, then V paced
- P-paced, V-paced (AP-VP): Both chambers paced; rate below LRL
- P-sensed, V-sensed (AS-VS): Intrinsic rhythm above LRL, both sensed, no pacing
- P-paced, V-sensed (AP-VS): Atrium paced, native AV conduction occurs
DDI
- Paces D, senses D, but does not track atrial activity - avoids pacemaker-mediated tachycardia
- Atrial sensing only inhibits atrial output; does not trigger ventricular output
- Useful when intermittent atrial tachyarrhythmias risk rapid ventricular pacing
VDD
- Senses both A and V, paces only V
- Atrial sensing triggers ventricular pacing (tracks P-waves)
- Adequate for AV block with intact sinus function
- Limitation: If sinus rate drops below LRL, the device paces the ventricle only (losing AV synchrony)
- Uses a single lead with floating atrial sensing electrodes
DDD Mode Timing Cycles (Braunwald):
- At rates below LRL: atria paced → V paced after AV interval
- At rates between LRL and URL: sensed P → V paced after AV interval (P-tracking)
- At rates above URL: 2:1 block or Wenckebach upper rate behavior
- Upper Rate Behavior: At atrial rates exceeding URL, the TARP causes 2:1 block. Just below that, Wenckebach-like upper rate behavior occurs as the device delays VP to maintain TARP.
Mode Enhancements
ADI/R (Atrial-based pacing with minimal RV pacing)
Designed to reduce right ventricular pacing burden. The device operates like AAI/R but switches to DDD if a dropped beat is detected - "ADI/R with DDD backup."
Managed ventricular pacing (MVP) / Search AV+:
Algorithms that extend the AV interval or switch to AAI(R) to allow intrinsic AV conduction, minimizing unnecessary RV pacing. The MOST trial showed increased AF and heart failure with higher RV pacing frequency in SSS patients.
4. Rate-Responsive Pacing (Braunwald, Ch. 69)
The addition of R to the mode code (e.g., VVIR, DDDR, AAIR) indicates rate-adaptive pacing. This is critical because the most important mechanism for increasing cardiac output with exercise is heart rate augmentation - stroke volume can only rise modestly.
Sensors Used:
| Sensor | Mechanism | Strengths | Limitations |
|---|
| Accelerometer | Detects body motion/vibration | Simplest, widely used | May increase rate in car passengers; misses isometric exercise |
| Minute ventilation | Chest impedance measures respiratory effort | Good correlation with metabolic demand | May oversense with upper limb movement |
| RV lead impedance | Correlates with contractility | Physiologic | Less validated |
| QT interval | Shortens with catecholamines/exercise | Proportional to rate need | Affected by drugs |
| Central venous temperature, pH, dP/dt | Metabolic demand | Theoretical advantage | Limited clinical use |
Most widely used: Accelerometers, with minute ventilation as second most common (Braunwald).
In rate-responsive modes, the device paces at LRL at rest and increases up to the programmed upper rate limit based on sensor output.
5. His Bundle and Left Bundle Branch Area Pacing (Conduction System Pacing)
This represents the most important evolution in pacing technology in the past decade. Both Braunwald and Fuster/Hurst dedicate significant coverage to this.
His Bundle Pacing (HBP) (Braunwald, Ch. 69; Fuster, Ch. 38)
- First reported in a small cohort in 2000; field expanded rapidly after 2014
- Selective HBP: Only His bundle captured - narrow QRS, 35 ms isoelectric interval between pacing spike and QRS (= HV interval)
- Non-selective HBP: His bundle + local ventricular myocardium captured - slight delta-like morphology
- Advantages: Maintains synchronous ventricular activation via native Purkinje system; corrects LBBB morphology in ~70% of patients; no ventricular dyssynchrony
- Limitations: Higher/unstable thresholds; technically challenging; potential for far-field sensing
Left Bundle Branch Area Pacing (LBBAP) (Braunwald, Ch. 69; Fuster, Ch. 38)
- Lead screwed deep into the interventricular septum to capture the left bundle branch or its fascicles
- Selective LBBAP: Only LBB captured - produces narrow QRS
- Non-selective LBBAP: LBB + local septal myocardium - RBBB morphology with LBB capture characteristics
- ECG hallmark: R-wave in V1 plus narrow QRS, or short latency and characteristic V1 morphology
- Advantages over HBP: Lower and more stable thresholds; easier implant; can "rescue" failed HBP
- The 2026 meta-analysis (PMID 41957548) confirms LBBAP superior to RV pacing in conduction disorders
Biventricular Pacing (Cardiac Resynchronization Therapy - CRT)
- Simultaneous or near-simultaneous pacing of RV + LV via coronary sinus branch lead
- Corrects interventricular and intraventricular dyssynchrony caused by LBBB
- Indication (Class I): LVEF ≤35%, LBBB morphology, QRS ≥150 ms, NYHA II-IV on GDMT
- Upgrade from RV pacing to CRT is now preferred over continued RV pacing in those who develop pacing-induced cardiomyopathy (meta-analysis PMID 36352513)
- Biventricular vs. Conduction System Pacing: CSP (HBP/LBBAP) is increasingly considered equivalent or superior to biventricular pacing; meta-analysis (PMID 40644356) shows CSP ≥ BiV pacing after AV node ablation
6. Hemodynamic Aspects of Pacing (Braunwald, Ch. 69)
- Severe bradycardia with junctional/ventricular escape: ventricular pacing at normal rates increases cardiac output by 25-30%
- Restoring AV synchrony augments cardiac output by an additional 20%
- Chronotropic response (rate responsiveness) is dominant over AV synchrony in improving exercise capacity
- Optimal AV interval: ~150 ms at rest, somewhat less with exertion
Pacemaker Syndrome
- Occurs in 3-30% of patients with ongoing sinus activity subjected to VVI pacing
- Mechanism: atrial contractions against closed AV valves → retrograde VA conduction → cannon A waves → fall in BP, rise in pulmonary venous pressure
- Manifestations: fatigue, dyspnea, dizziness, neck pulsations (cannon waves), chest pain, hypotension, syncope
- Treatment: upgrade to dual-chamber pacing; dual-chamber pacing reduces stroke, AF occurrence, and improves quality of life vs. VVI
Right Ventricular Pacing-Induced Cardiomyopathy (Fuster, Ch. 38)
- Approximately 12-22% of patients with significant RV pacing develop cardiomyopathy
- Mechanism: RV apical pacing mimics LBBB - intraventricular dyssynchrony, regional wall strain abnormalities, LV remodeling
- Risk increases with QRS prolongation and worse baseline LV function
- DAVID trial: dual-chamber pacing with high RV pacing rate increased composite HF/death by 1.6× vs. backup VVI
- MOST trial: increased RV pacing frequency in SSS associated with increased AF and HF
- Strategy: minimize RV pacing via MVP/ADI algorithms OR use conduction system pacing
7. Abnormal Pacemaker Rhythms / Pacemaker Malfunction
A. Failure to Pace (No Output)
- Causes: Battery depletion, lead fracture, connector block disconnect, oversensing (inappropriate inhibition)
- ECG: No pacing spike when expected; rate falls below LRL
B. Failure to Capture
- Causes: Lead displacement (most common - early), increased threshold (fibrosis, drugs - Class 1C, amiodarone), perforation, exit block
- ECG: Pacing spike present but NOT followed by a P or QRS complex
- Drugs that raise threshold: Flecainide, chronic amiodarone (especially atrial thresholds)
- Drugs that lower threshold: Glucocorticoids, isoproterenol, epinephrine
C. Oversensing (Inappropriate Inhibition)
- Device senses non-cardiac signals (T waves, myopotentials, EMI, crosstalk) and is inappropriately inhibited
- Crosstalk: Ventricular channel senses atrial pacing spike → inhibits ventricular output (dangerous in pacemaker-dependent patients)
- Myopotential oversensing: More common with unipolar leads
- EMI sources: MRI (requires specific MRI-conditional devices), electrocautery, arc welders, strong magnets
- ECG: Unexplained pauses; pacing spikes absent
D. Undersensing
- Device fails to sense native cardiac activity → paces too frequently or at inappropriate times
- Causes: Lead displacement, low signal amplitude, lead fibrosis, oversized sensing threshold
- ECG: Pacing spikes that fall on or near native beats; escape interval shorter than programmed (Braunwald eFig. 69.9)
E. Pacemaker-Mediated Tachycardia (PMT) (Braunwald; Fuster)
- Occurs in dual-chamber pacemakers
- Mechanism: A PVC or premature beat conducts retrogradely to atrium → retrograde P-wave sensed outside PVARP → triggers ventricular pacing → another retrograde P → endless loop tachycardia
- Rate: = URL (upper rate limit) of the pacemaker - often a sudden jump to 120-150 bpm
- Management: Place magnet (converts to asynchronous, breaks loop); reprogram - lengthen PVARP; reprogram PMT detection algorithm
- Fuster (Ch. 38): PMT can usually be corrected by reprogramming
F. Runaway Pacemaker
- Rare; catastrophic battery depletion or component failure → pacing at very high rates (>200 bpm)
- Management: Magnet placement; device replacement emergency
G. Pacing-Induced Proarrhythmia (Braunwald, Ch. 69)
- RV pacing itself can produce QRS prolongation and trigger arrhythmias
- "Pacing-induced proarrhythmia" - documented but uncommon in isolation
- Torsades de pointes can occur with pause-dependent QT prolongation in bradycardic patients
H. Unexpected Drop in Pacing Rate
- Rate hysteresis: Intentional design - LRL is lower than escape interval; device waits longer before initiating pacing (promotes intrinsic rhythm)
- Battery depletion (ERT/EOL indicators): Rate drop to magnet/backup rate indicates battery near end of life
- Mode switch: Device may switch from DDDR to VVIR during AF → apparent rate change
8. Special Pacing Rhythms on ECG
| Rhythm/Pattern | Description |
|---|
| Atrial pacing | Pacing spike before P wave; P morphology different from sinus if from right atrium |
| Ventricular pacing | Wide QRS (LBBB morphology with RV apex pacing); pacing spike immediately before wide QRS |
| AV sequential pacing | Two spikes - one before P, one before wide QRS; fully paced rhythm |
| P-synchronous ventricular pacing | Native P wave tracked by device → ventricular spike + wide QRS after AV delay |
| VVI paced rhythm | Wide QRS complexes at set rate when native rate falls below LRL; no atrial spikes |
| His bundle paced | Pacing spike + narrow QRS (if selective); isoelectric interval between spike and QRS = HV interval |
| LBBAP | Pacing spike + narrow QRS; RBBB-like in V1 with short latency; deep S in V6 |
| Biventricular paced | Pacing spike + fusion of RV and LV activation; QRS narrower than LBBB, RBBB or intermediate morphology |
| Pacemaker Wenckebach | Progressive lengthening of AV interval (VAV interval) until a P-wave falls in PVARP → dropped VP; analogous to Wenckebach |
| 2:1 pacemaker block | Every other P-wave falls in TARP → only every other P tracked → ventricular rate = ½ atrial rate |
| PMT | Sudden tachycardia at URL; P-wave after QRS (retrograde) if visible |
| Pseudofusion | Pacing spike falling on native beat (spike visible but native beat already occurring); no additional activation |
| Fusion beat | Simultaneous pacing and intrinsic activation of same chamber; intermediate QRS morphology |
9. Indications for Permanent Pacing (AHA/ACC 2018/2019 Guidelines - as cited in Fuster, Ch. 38)
Sinus Node Dysfunction (SND)
- Class I (Recommended): Symptomatic bradycardia or pauses caused by SND
- Class I: Symptomatic chronotropic incompetence
- Class III (Harm): Asymptomatic sinus bradycardia or physiologic/sleep-related pauses; SND due to reversible causes
Mode of choice: DDDR (preferred); AAIR if no AV conduction disease; VVIR if permanent AF (Fuster, Ch. 38). SND accounts for 42-60% of new pacemaker implants in North America.
AV Block (Fuster, Table 39-4)
- Class I: Second-degree Mobitz type II (trifascicular block), high-grade AV block, or complete (third-degree) AV block - permanent pacing regardless of symptoms
- Class I: Neuromuscular diseases (myotonic dystrophy, Kearns-Sayre syndrome) with severe AV block or HV interval ≥70 ms
- Class I: Permanent AF with symptomatic bradycardia
- Class I: Drug-induced AV block where drug is necessary and no alternatives exist
- Class IIa: Infiltrative cardiomyopathy (sarcoidosis, amyloidosis) + Mobitz II/high-grade/complete AV block
- Class IIa: Lamin A/C gene mutations (limb-girdle, Emery-Dreifuss muscular dystrophy) + PR >240 ms + LBBB
Mode of choice for AV block:
- Complete AV block: dual-chamber (DDDR) to maintain AV synchrony
- Normal sinus function + AV block: VDD (single-lead dual-chamber tracking)
- Permanent AF + bradycardia: VVIR adequate
- SND + AV block: DDDR
Post-Cardiac Surgery/TAVR (Fuster, Table 38-6)
- Class I: New SND or AV block after CABG, AVR, MVR/repair, TVR repair causing symptoms or hemodynamic instability - permanent pacing before discharge
- Class I: New AV block after TAVR with symptoms/hemodynamic instability not resolving
10. Leadless Pacemakers (Fuster, Ch. 38)
Two commercially available systems:
| Feature | Nanostim LCP (Abbott) | Micra TCP (Medtronic) |
|---|
| Fixation | Active helix | Nitinol tines |
| Site | RV | RV apical septum |
| Trial | LEADLESS II (526 pts) | Micra TCP (725 pts) |
| Implant success | 95.8% | 99.2% |
| Major complication (6 mo) | 6.7% | 4% |
| Complications | Dislodgement 1.7%, perforation 1.3% | Perforation/effusion 1.6% |
- Post-Approval Registry (Micra, 1817 patients): 99.1% implant success; 2.7% major complications (66% less than IDE study)
- Indications: Primarily permanent AF with bradycardia, SND, AV block where single-chamber ventricular pacing is sufficient
- Limitation: No atrial pacing; no AV synchrony; however, newer dual-chamber leadless systems (Micra AV) can sense atrial contraction via RV accelerometer and provide AV-synchronous pacing
11. Antitachycardia Pacing (ATP) (Braunwald, Ch. 69)
- Delivered by ICDs to terminate ventricular tachycardia
- Burst pacing at a rate slightly faster than VT rate captures the reentrant circuit and terminates VT
- Burst ATP: All stimuli at same short cycle length
- Ramp ATP: Progressively decreasing cycle lengths (accelerating)
- ATP avoids painful defibrillation shocks; effective for slower VT (<200 bpm)
- Risk: ATP can accelerate VT - always backed by shock therapy in ICD
12. Drug Interactions with Pacemakers (Braunwald, Table 69.1)
| Drug Effect | Drugs |
|---|
| Raise pacing threshold | Class 1C (flecainide); chronic amiodarone (especially atrial) |
| Lower pacing threshold | Glucocorticoids; isoproterenol; epinephrine |
| Increase atrial pacing burden | Beta-blockers, amiodarone, lithium (cause sinus bradycardia) |
| Increase ventricular pacing burden | Beta-blockers, amiodarone (slow AV conduction) |
13. Key Summary: Pacing Mode Selection
| Clinical Situation | Recommended Mode |
|---|
| SSS, no AV disease | AAIR |
| SSS, possible AV disease | DDDR |
| Permanent AF + bradycardia | VVIR |
| AV block, normal sinus | VDD or DDDR |
| SSS + AV block | DDDR |
| AV block, permanent AF | VVIR |
| LBBB + reduced EF (CRT) | DDD-BiV or CSP |
| Pacemaker-dependent, OR | VOO (via magnet) or programmed asynchronous |
| Chronotropic incompetence | Any mode + R (rate-responsive) |
Recent Evidence Update (PubMed, 2022-2026)
- [PMID 41957548] (Clin Cardiol 2026): Meta-analysis confirms Left Bundle Branch Area Pacing (LBBAP) is superior to RV pacing in conduction system disorders - lower QRS duration, better LVEF preservation
- [PMID 40644356] (Europace 2025): Conduction system pacing ≥ biventricular pacing after AV node ablation - equivalent or better outcomes
- [PMID 36352513] (Europace 2023): Upgrading RV pacemakers to biventricular or CSP pacing - systematic review supports clinical benefit in pacing-induced cardiomyopathy
- [PMID 39892565] (Int J Cardiol 2025): Rate-adaptive pacing significantly improves exercise capacity and quality of life in chronotropic incompetence
Key Figures Available in Braunwald's (Ch. 69)
The textbook contains several key figures including:
- Figure 69.6: Permanent His bundle pacing - 12-lead ECG showing atrial-synchronous ventricular pacing with narrow QRS; isoelectric HV interval between spike and QRS; X-ray showing lead positions
- eFigure 69.7: Left bundle branch area pacing - V1-V3 comparison of BiV vs. LBBAP with QRS duration comparison; lead placement with contrast injection; PA and lateral X-rays
- Figure 69.7: Pacing lead design - passive vs. active fixation; coaxial vs. coradial lead construction
- Figure 69.9: Single chamber modes - VOO, VVI, AAI timing cycles
- eFigure 69.8: DDI and DDD pacing mode timing diagrams
Primary references: Braunwald's Heart Disease, 11e, Chapter 69 (Pacemakers/ICDs) | Fuster and Hurst's The Heart, 15th Ed, Chapters 38-39 (Cardiac Pacing) | AHA/ACC 2018 Bradycardia/CRS Pacemaker Guidelines